FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)

View source ↗

Summary

FDA approved the Original Application for Fludeoxyglucose F-18 (FDG F-18) radiopharmaceutical for PET imaging, establishing its labeling and indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Coronary Artery Disease
• Epilepsy

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F 18 (FLUDEOXYGLUCOSE F-18)